Price

rebased to 0%

PFE, solidMRK, dashed

PFEPfizer Inc

30.71+0.62%· post 31.03

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

MRKMerck & Co., Inc.

148.44−0.72%· post 149.04

ClosedNov 2 '26

Mkt cap$366.0BRevenue$16.6BQ2 FY26Revenue$65.0BFY25

vs

Compare

ClosedNov 2 '26

PFEPfizer Inc

vs

MRKMerck & Co., Inc.

30.71+0.62%post 31.03

Price

148.44−0.72%post 149.04

$174.0B

Mkt cap

$366.0B

Q2 FY26$15.0B

Revenue

$16.6BQ2 FY26

FY25$62.6B

Revenue

$65.0BFY25

PFE compared with MRK: revenue, margins and what each company keeps, and the suppliers and customers both name